Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Directors of Department in Hospital| Tongji University | China

Dr. Shaoqing Yu, PhD, is the Director of the Departments of Otorhinolaryngology–Head and Neck Surgery and Allergy at Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. An accomplished clinician-scientist, Dr. Yu specializes in allergy, immunology, and otorhinolaryngology, with a research focus on the mechanisms and clinical management of allergic rhinitis and upper airway inflammation. He has led or participated in more than 20 major research projects, including those funded by the National Natural Science Foundation of China, and has published over 70 peer-reviewed papers in high-impact international journals such as JAMA, Allergy, Clinical and Experimental Allergy, and Clinical Reviews in Allergy & Immunology. His work has substantially advanced understanding of immune regulation and translational therapies in allergic diseases. Dr. Yu is an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and the Chinese Society of Otolaryngology in Traditional Chinese and Western Medicine, fostering global and interdisciplinary collaborations. His achievements have been recognized through numerous awards, including the Third Prize of the Shanghai Medical Technology Award, the Third Prize of the Military Medical Achievement Award, and the Tongji University Taihe Medical Education Award. With over 20 patents to his name and selection for the prestigious Shanghai Oriental Talent Plan, Dr. Yu continues to contribute significantly to medical innovation, education, and the improvement of public health outcomes in China and internationally.

Profiles: Scopus | ORCID 

Featured Publications

Yu, S., et al. (2025). An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: The DUBHE randomized clinical trial. Nature Communications.

Yu, S., et al. (2025). Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis. International Immunopharmacology.

Yu, S., et al. (2025). Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2⁺ CD8⁺ T effector cells. Cell Metabolism.

Yu, S., et al. (2025). Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment. Translational Andrology and Urology.

Yu, S., et al. (2025). Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways. Translational Andrology and Urology.

Dr. Shaoqing Yu’s pioneering research in allergy and immunology has advanced understanding of airway inflammatory diseases and driven the development of innovative diagnostic and therapeutic strategies. His work bridges basic science and clinical application, improving patient outcomes and shaping global standards in allergic disease management.

An Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Published on by Global Scholar Awards

Dr. Ana Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Universidad Marista, Mexico

Ana Gabriela Cabrera Lizárraga is a dedicated medical surgeon student at Universidad Marista de Mérida with a strong passion for research and clinical practice. She has actively participated in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula, focusing on genetic disorders, clinical case studies, and biomedical advancements. Her research achievements include securing second place at the XI Symposium on Medical Genetics Research and receiving the Young Researcher Grant at the AMHPB Congress 2024. With a high academic standing (GPA 93.06/100), she has also contributed to symposiums and journal clubs. Ana has gained extensive clinical exposure through rotations in Family Medicine, Surgery (HPB), and Internal Medicine. Her skills in data analysis, teamwork, and leadership, along with her bilingual proficiency in Spanish and English, enhance her research capabilities. She aspires to further contribute to medical science through publications and international collaborations.

Professional Profile 

Education

Ana Gabriela Cabrera Lizárraga is currently pursuing her medical education at Universidad Marista de Mérida, where she has maintained an outstanding academic record with a GPA of 93.06 (0-100). Her educational journey began at Colegio Mérida A.C. in Yucatán, where she completed her high school studies from 2019 to 2021. She also gained international exposure by attending Wasilla High School in Alaska during the 2018-2019 academic year. Her commitment to academic excellence is complemented by her participation in specialized courses, including the PREMED II Course at Universidad Panamericana and multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula. Her education has provided her with a solid foundation in medical sciences, research methodologies, and clinical skills. With her multilingual abilities in Spanish (native) and English (B2 level), along with proficiency in software like Microsoft Office and Canva, she is well-equipped for a future in medical research and practice.

Professional Experience

Ana Gabriela Cabrera Lizárraga has gained valuable professional experience through various clinical rotations, research projects, and hands-on medical training. She has completed rotations in Family Medicine at IMSS (UMF.52 and UMF.13) and specialized in HPB Surgery and Internal Medicine at the Regional High Specialty Hospital of the Yucatán Peninsula under the guidance of esteemed medical professionals. Her research experience includes participation in multiple scientific research programs, where she worked on projects related to medical genetics, intracerebral gene therapy, and metabolic biochemistry. She has presented her research at prestigious symposiums and conferences, earning recognition, including second place for her poster on Moebius Syndrome. Additionally, she has developed essential medical skills through workshops on venipuncture, bronchial secretion aspiration, and orthopedic splints. Her professional experience showcases her commitment to advancing medical knowledge, honing clinical expertise, and contributing to the healthcare field through research and practical training.

Research Interest

Ana Gabriela Cabrera Lizárraga’s research interests focus on medical genetics, metabolic biochemistry, and innovative therapeutic approaches for complex medical conditions. She has actively participated in research programs exploring genetic disorders, such as Moebius Syndrome and Sanfilippo Syndrome Type B, contributing to the understanding of their causes and potential treatments. Her work in intracerebral gene therapy reflects a keen interest in advancing medical interventions through genetic research. Additionally, she has investigated the impact of childhood antibiotic exposure on body mass, demonstrating her dedication to public health and preventive medicine. Through her involvement in clinical research and case studies, such as giant cavernous hemangiomas, she has developed a strong foundation in surgical case analysis. Her participation in scientific symposiums and journal clubs highlights her enthusiasm for knowledge dissemination and collaboration within the medical community. Ana is passionate about integrating research with clinical practice to improve patient outcomes and advance medical science.

Award and Honor

Ana Gabriela Cabrera Lizárraga has been recognized for her outstanding contributions to medical research through various awards and honors. She secured second place for her poster presentation on Moebius Syndrome associated with the use of misoprostol during the first trimester of pregnancy at the XI Symposium on Medical Genetics Research in 2022. Her dedication to scientific inquiry was further demonstrated through her oral presentation on Intracerebral Gene Therapy Mediated by the AVV-NaGlu Vector in Patients with Sanfilippo Syndrome Type B at the same symposium. Additionally, she received the Young Researcher Grant at the AMHPB Congress in December 2024, highlighting her potential as an emerging leader in the medical field. Ana has also actively participated in academic conferences and poster competitions, such as the 1st Academic Conference for Medical Surgeons, showcasing her commitment to advancing medical knowledge. Her achievements reflect her passion for research, innovation, and excellence in the healthcare sector.

Research Skill

Ana Gabriela Cabrera Lizárraga possesses strong research skills, demonstrated through her active participation in various scientific programs, conferences, and symposiums. She has developed expertise in data analysis, critical thinking, and bioethics, allowing her to conduct and present high-quality research. Her involvement in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula has provided her with hands-on experience in clinical research methodologies. Ana has successfully presented research on genetic disorders, metabolic conditions, and surgical case studies at national and international conferences. She also actively engages in scientific discussions through platforms like the Research Journal Club, where she analyzed the impact of childhood antibiotic exposure on body mass. Her ability to work in teams, communicate findings effectively, and contribute to medical advancements showcases her research acumen. Ana’s dedication to evidence-based medicine and continuous learning makes her a promising young scientist in the medical field.

Conclusion

Ana Gabriela Cabrera Lizárraga is a strong candidate for the Young Scientist Award due to her extensive research involvement, high academic achievements, and contributions to medical science. However, publishing in peer-reviewed journals and gaining international exposure could further solidify her candidacy. Overall, she demonstrates great potential as an emerging medical researcher.

Publications Top Noted

​Title: Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis​

Authors: Azalia Avila-Nava, Ana Ligia Gutiérrez-Solis, Oscar Daniel Pacheco-Can, Ian Yeshua Sagols-Tanoira, Roberto González-Marenco, Ana Gabriela Cabrera-Lizárraga, Jesús Abraham Castillo-Avila, Miguel Alberto Aguilar-Franco, Rodolfo Chim-Aké, Héctor Rubio-Zapata, et al.​

Year: 2025​

Citation: Avila-Nava, A., Gutiérrez-Solis, A.L., Pacheco-Can, O.D., Sagols-Tanoira, I.Y., González-Marenco, R., Cabrera-Lizárraga, A.G., Castillo-Avila, J.A., Aguilar-Franco, M.A., Chim-Aké, R., Rubio-Zapata, H., et al. (2025). Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis. Foods, 14(6), 1052. https://doi.org/10.3390/foods14061052

Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Faculty Member at Gaziantep University, Faculty of Medicine, Turkey

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı is a distinguished radiologist and researcher specializing in breast imaging, oncological radiology, and artificial intelligence applications in medical diagnostics. Currently serving at Gaziantep University, she holds a European Diploma in Radiology and multiple academic certifications, reflecting her expertise. With a strong research portfolio, she has published extensively in high-impact journals, including the New England Journal of Medicine and Academic Radiology. Her work focuses on improving diagnostic accuracy in breast cancer and exploring advanced imaging techniques. In addition to her medical background, she holds a master’s degree in breast imaging technologies and an associate degree in English translation, showcasing her interdisciplinary skills. Recognized for her contributions to radiology, she continues to advance the field through international collaborations and innovative research. Her commitment to academic excellence and clinical advancements makes her a strong candidate for prestigious research awards in medical science.

Professional Profile

Education

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has a comprehensive educational background in medicine and radiology. She earned her medical degree from Ege University Faculty of Medicine in 2010, followed by a specialization in radiology at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted research on advanced imaging techniques for Crohn’s disease. She further specialized in breast imaging, completing a thesis-based master’s degree at Acıbadem Mehmet Ali Aydınlar University’s Senology Research Institute, focusing on tumor size correlation in breast cancer. In addition to her medical education, she pursued an associate degree in Applied English and Translation at Istanbul Arel University, demonstrating her interdisciplinary expertise. Her academic achievements are complemented by prestigious certifications, including the European Diploma in Radiology (EDIR) and the Turkish Society of Radiology Proficiency Test (TRD), highlighting her commitment to continuous learning and excellence in radiology.

Professional Experience

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has extensive professional experience in radiology, medical education, and research. She currently serves as an Associate Professor at Gaziantep University, Faculty of Medicine, Department of Radiology, where she contributes to clinical practice, academic teaching, and advanced imaging research. Previously, she worked as an Assistant Professor at both Gaziantep University and Istanbul Rumeli University, gaining experience in medical education and training future healthcare professionals. Her career began as a Research Assistant at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted specialized research in diagnostic imaging. Over the years, she has earned several professional certifications, including the European Diploma in Radiology (EDIR) and the Interventional Radiology Diploma (TGRD), demonstrating her expertise in both diagnostic and interventional radiology. With a strong publication record and contributions to international collaborations, she continues to make significant advancements in the field of radiology and medical imaging.

Research Interest

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Award and Honor

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has received several prestigious awards and honors in recognition of her contributions to radiology and medical research. She holds the European Diploma in Radiology (EDIR), a distinguished certification granted by the European Society of Radiology, highlighting her expertise in diagnostic imaging. She also earned the Interventional Radiology Diploma (TGRD) after successfully completing rigorous training and examinations in Turkey. Additionally, she was awarded the Turkish Society of Radiology Proficiency Test (TRD) Certification, further demonstrating her excellence in the field. Her research has been published in high-impact journals such as the New England Journal of Medicine and Academic Radiology, earning her recognition in the global medical community. Through her dedication to advancing radiology, she continues to contribute to innovative imaging techniques and cancer diagnostics, positioning herself as a leading researcher in her field. Her achievements reflect her commitment to academic and clinical excellence.

Research Skill

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Conclusion

Dr. Deniz Esin Tekcan Şanlı is a highly qualified researcher with significant contributions to radiology and oncology, making her a strong candidate for the Best Researcher Award. Her extensive publication record, academic achievements, and interdisciplinary expertise stand out. Strengthening her profile with more leadership roles in major research projects, grant acquisition, and innovation-related contributions would further solidify her candidacy.

Publications Top Noted

  • Gastrointestinal Kaposi’s Sarcoma
    Authors: Deniz Esin Tekcan Şanlı, Şafak Kızıltaş
    Year: 2023
    Citation: New England Journal of Medicine (NEJM), 2023. https://www.nejm.org/doi/pdf/10.1056/NEJMicm2102502

  • Correlation of Radiological and Pathological Tumor Sizes in Breast Cancer Based on Molecular Subtypes and Accompanying DCIS
    Authors: Deniz Esin Tekcan Şanlı, Gül Esen Icten, et al.
    Year: 2025
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2025.01.037

  • Artificial Intelligence for Early Detection of Breast Cancer
    Authors: TEKCAN ŞANLI DENİZ ESİN, ALAKUŞ HAKAN
    Year: 2024
    Citation: Die Onkologie, DOI: 10.1007/s00761-024-01654-4

  • Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(11):2745-2755. DOI: 10.1177/00031348241248695

  • Should the Breast Cancer Staging System be Revised?
    Authors: Sanli AN, Tekcan Sanli DE, Aydogan F, Altundag MK
    Year: 2024
    Citation: Am Surg., 2024; 90(5):1066-1073. DOI: 10.1177/00031348231223074

  • Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(4):788-799. DOI: 10.1177/00031348231212588

  • Secretory Carcinoma of Breast: A Population-Based Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(2):252-260. DOI: 10.1177/00031348231199174

  • Linear Regression Modeling-Based Scoring System to Reduce Benign Breast Biopsies Using Multi-Parametric US with Color Doppler and SWE
    Authors: Erkin Arıbal, Burcu Özdemir, Onur Buğdaycı, Gökhan Ertaş, Deniz E T Şanlı, Handan Kaya
    Year: 2023
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2023.01.024

  • Could DTI Unlock the Mystery of Subjective Tinnitus?
    Authors: YILMAZ EREN, YILDIRIM DÜZGÜN, TEKCAN ŞANLI DENİZ ESİN, ELPEN KARYEMEZ FATMA PINAR, et al.
    Year: 2024
    Citation: Indian Journal of Otolaryngology and Head & Neck Surgery, 76, 5277-5284. DOI: 10.1007/s12070-024-04963-7

  • Comparison of Magnetic Seed and RFID Methods in the Localization of Non-Palpable Breast Lesions
    Authors: ŞANLI AHMET NECATİ, TEKCAN ŞANLI DENİZ ESİN, et al.
    Year: 2024
    Citation: Journal of Cancer Research and Therapeutics, 20(5), 1435-1439. DOI: 10.4103/jcrt.jcrt_2253_22

  • CT-Guided Percutaneous Biopsies in the Abdomen and Pelvis
    Authors: TEKCAN ŞANLI DENİZ ESİN, WEBER JEAN PHILIP, MAINTZ DAVID
    Year: 2024
    Citation: Die Onkologie, 30, 875-876. DOI: 10.1007/s00761-024-01576-1

  • Normative Reference Values of Major Thoracic Arterial Vasculature in Turkey
    Authors: Deniz Esin Tekcan Şanlı, Ahmet Necati Şanlı, Onur Yıldırım, Ergin Erginöz, Düzgün Yıldırım
    Year: 2023
    Citation: Northern Clinics of Istanbul, DOI: 10.14744/nci.2021.03206

  • Evaluating Portal Vein and Right Colon Venous Vascular Anatomy and Its Variations via Multidetector CT in Healthy Individuals
    Authors: Uludag, S.S., Kurt, S.A., Sanli, D.E.T. et al.
    Year: 2022
    Citation: Indian Journal of Surgery, 84, 1292–1302. DOI: 10.1007/s12262-022-03583-1

  • CT Findings of the Massive Air Embolism in a Case with Thoracic Gunshot Wound: A Special Case Report as if a Whole Body Pneumo-Angiography was Performed
    Authors: Zeynalova, Amalya; Sanli, Deniz E.T.; Agar, Emir H.; Yildirim, Duzgun; Tuzuner, Filiz
    Year: 2022
    Citation: Current Medical Imaging, 18(11), 1253-1256. DOI: 10.2174/0929866529666220426121222

  • A New Imaging Sign in COVID-19 Pneumonia: Vascular Changes and Their Correlation with Clinical Severity of the Disease
    Authors: Tekcan Şanlı DE, Yıldırım D.
    Year: 2020
    Citation: Diagnostic and Interventional Radiology, DOI: 10.5152/dir.2020.20346

David Kopsky | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Mr. David Kopsky | Medicine and Dentistry | Best Researcher Award

Anesthesiology at Amsterdam medical center, Netherlands

Dr. David J. Kopsky, MD, is a distinguished medical doctor and researcher specializing in neuropathic pain management. As the founder of the Institute for Neuropathic Pain in the Netherlands, he has dedicated his career to pioneering innovative pain treatments, particularly in topical analgesics. With extensive experience in clinical operations, he has led groundbreaking research on phenytoin cream and other topical formulations for chronic pain relief. Dr. Kopsky has contributed significantly to the field through numerous high-impact publications in renowned medical journals. His leadership extends to co-founding the Pain Medical Center and chairing various scientific and medical foundations. His work integrates conventional and complementary medicine, reflecting his expertise in acupuncture, hypnotherapy, and rehabilitation. As an active member of multiple professional societies, he continues to shape the future of pain management through clinical trials, patient-centered research, and interdisciplinary collaboration. His contributions make him a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. David J. Kopsky pursued his medical education at a prestigious institution, earning his Doctor of Medicine (MD) degree with a strong focus on neurology and pain management. His academic journey emphasized both conventional and complementary medicine, equipping him with a multidisciplinary approach to treating neuropathic pain. Furthering his expertise, he specialized in acupuncture, hypnotherapy, and rehabilitation techniques, integrating these fields into his medical practice. Dr. Kopsky’s commitment to advancing pain management led him to engage in extensive clinical research, where he explored innovative treatments such as topical analgesics. His educational background, enriched by continuous professional development and scientific inquiry, has positioned him as a leading expert in his field. Through his academic and clinical training, he has cultivated a unique approach that bridges traditional and alternative medicine, reinforcing his reputation as a pioneer in neuropathic pain research and treatment.

Professional Experience

Dr. David J. Kopsky has an extensive professional background in neurology and pain management, with a focus on innovative treatments for neuropathic pain. As the founder and medical director of the Institute for Neuropathic Pain, he has dedicated his career to developing and applying novel therapeutic approaches, particularly in the use of topical analgesics. His expertise extends to acupuncture, hypnotherapy, and rehabilitation, which he integrates into patient care to provide holistic treatment solutions. Dr. Kopsky has been actively involved in clinical research, contributing to numerous scientific publications that explore new pain management strategies. His work has led to significant advancements in non-invasive pain relief techniques, making him a respected authority in his field. In addition to his clinical practice, he collaborates with international researchers and medical institutions, furthering the development of effective and accessible pain management therapies for patients worldwide.

Research Interest

Dr. David J. Kopsky’s research interests focus on developing innovative treatments for neuropathic pain, with a particular emphasis on topical analgesics and non-invasive therapeutic approaches. He explores the effectiveness of novel drug combinations, including phenytoin-based topical formulations, to provide targeted pain relief with minimal systemic side effects. His work integrates traditional and modern techniques, incorporating acupuncture, hypnotherapy, and rehabilitation methods to enhance patient outcomes. Dr. Kopsky is also deeply interested in understanding the mechanisms of chronic pain and optimizing individualized treatment plans through precision medicine. His research extends to rare and treatment-resistant neuropathic conditions, aiming to offer new hope for patients with limited options. Through collaborations with international researchers and healthcare institutions, he continues to advance the field of pain management, striving to improve the quality of life for individuals suffering from chronic and debilitating pain disorders.

Award and Honor

Dr. David J. Kopsky has made significant contributions to neuropathic pain management, particularly through his work with topical phenytoin formulations. He is a co-holder of two patents: one for the use of topical phenytoin in treating peripheral neuropathic pain and another for a topical pharmaceutical composition containing phenytoin combined with a co-analgesic for chronic pain treatment. Additionally, Dr. Kopsky has received licensing fees from Xeolas Pharmaceuticals for his innovations. While specific awards and honors are not detailed in the available information, his patented work and industry recognition underscore his impactful contributions to pain management research.

Research Skill

Dr. David J. Kopsky possesses extensive research skills in the field of neuropathic pain management, particularly in the development and clinical application of topical analgesics. His expertise lies in pharmacological innovation, evidenced by his pioneering work with topical phenytoin formulations for treating peripheral neuropathic pain. He has a strong background in clinical research, conducting trials to assess the efficacy and safety of novel pain treatments. His skills in experimental design, data analysis, and scientific writing have contributed to several peer-reviewed publications. Dr. Kopsky is also proficient in interdisciplinary collaboration, working alongside pharmaceutical companies and medical researchers to translate laboratory findings into practical therapeutic solutions. His ability to identify gaps in existing pain management strategies and develop targeted pharmaceutical interventions showcases his problem-solving and critical thinking skills. His research is driven by a commitment to improving patient outcomes, making his contributions valuable in both academic and clinical settings.

Conclusion

Dr. David J. Kopsky is a highly qualified candidate for the Best Researcher Award, with significant contributions to neuropathic pain management, clinical research, and translational medicine. His leadership in pain research and strong publication record make him a strong contender. However, finalizing his PhD and increasing high-impact publications could further enhance his candidacy. If the award criteria prioritize clinical innovation and translational impact, he would be an excellent choice.

Publications Top Noted

  • Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol

    • Authors: D.J. Kopsky, R.P.A. van Eijk, J.K. Warendorf, N.C. Notermans, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 2

  • Pulsed Radiofrequency Increases Nestin and Matrix Metalloproteinase-2 Expression in Porcine Lumbar Dorsal Root Ganglion

    • Authors: M. Arons, M. Pilmane, A.K. Bhaskar, V.I. Romanenko, O.J.J.M. Rohof
    • Year: 2022
    • Citations: 1

  • Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review

    • Authors: D.J. Kopsky, K.M. Szadek, P.R. Schober, A.F.J.E. Vrancken, M.A. Steegers
    • Year: 2022
    • Citations: 4

  • No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action

    • Authors: D.J. Kopsky, J.M. Keppel Hesselink, A.L. Russell, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 3